Press Releases

NEW YORK, Sept. 10, 2019 /PRNewswire/ -- The Lasker Foundation today announced the winners of its 2019 Lasker Awards: Max D. Cooper from Emory University and Jacques Miller from the Walter and Eliza Hall Institute of Medical Research will receive the Albert Laske

LEIDEN, Netherlands, Sept. 10, 2019 /PRNewswire/ -- Pharvaris B.V., a clinical-stage company focused on the discovery and development of novel oral B2-receptor antagonists for the treatm

DENVER, Sept. 10, 2019 /PRNewswire/ -- CereHealth Corporation through its subsidiary CereScan®, a national network of functional brain imaging and analytics centers, announced today that it has received approval of its Littleton, CO location as a qualified imaging facility for a Sun Pharma Advanced Research Company (S

LUFKIN, Texas, Sept. 10, 2019 /PRNewswire/ -- Dr. Charles Evans with The Institute for Lifestyle, Preventive and Family Medicine is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

DALLAS, Sept. 10, 2019 /PRNewswire/ -- Mara Pinney of Mara's Med Spa is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

JACKSONPORT, Miss., Sept. 10, 2019 /PRNewswire/ -- Mississippi Urology Clinic, PLLC is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

OWOSSO, Mich., Sept. 10, 2019 /PRNewswire/ -- The Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis, and its Chief of Neurology, Rany Aburashed, D.O., are the first in the U.S. to use Neurofilament Light Chain testing prospectively for patients with multiple sclerosis. The study, aimed at 1,000 patients will use the te

MONTREAL and CHARLOTTE, N.C., Sept. 10, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced the appointment of Amit Hasija

STAINES-UPON-THAMES, United Kingdom and MIAMI, Sept. 10, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biop

CLEVELAND, Sept. 10, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® and MRIdian Linac MRI-guided radiation therapy systems will be featured at the 2019 Annual Meeting of the American Society for Radiation Oncology (ASTRO), being held September 15-19, 2019 in C